Pharmaceutical Technology

OCTOBER 14, 2022

Merck Research Laboratories chief medical officer, global clinical development head and senior vice-president Dr Eliav Barr said: “This long-term collaboration combining Merck’s expertise in immuno-oncology with Moderna’s pioneering mRNA technology has yielded a novel tailored vaccine approach.

Vaccines 115

Vaccines Research Laboratories Immunity Immunization 115

Express Pharma

JANUARY 30, 2024

The facility will focus on developing next-generation molecules using generative AI platforms, particularly in the ophthalmic, ENT, Paediatrics and skincare segments ENTOD Pharmaceuticals has inaugurated its state-of-the-art Research & Development Centre in Navi Mumbai on Sunday, January 28th.

Research Laboratories 109

Research Laboratories 109

European Pharmaceutical Review

APRIL 17, 2023

“I look forward to working with the Prometheus team to establish a new paradigm of precision treatment for immune diseases,” commented Dr Dean Y Li, President of Merck Research Laboratories.

Research Laboratories 105

Research Laboratories Immunity Immunization 105

Pharmaceutical Technology

JULY 13, 2022

Merck Research Laboratories president Dr Dean Li said: “Targeting CYP11A1 provides a compelling approach to suppressing the production of steroid hormones, a key driver of prostate cancer. “We The latest deal complements and bolsters the oncology pipeline of Merck.

Research Laboratories 105

Research Laboratories Vaccines 105

pharmaphorum

JANUARY 28, 2022

. “This approval demonstrates our progress in bringing Keytruda to patients with earlier stages of cancer, with the goal of helping more patients around the globe prevent disease recurrence,” said Scot Ebbinghaus, head of clinical research at Merck Research Laboratories.

Research Laboratories 111

Research Laboratories 111

European Pharmaceutical Review

DECEMBER 15, 2023

The companies also plan to expand the development programme to additional tumour types.

Vaccines 115

Vaccines Research Laboratories Immunity Immunization 115

Pharmacy Is Right For Me

APRIL 3, 2023

Pharmacists can work in a variety of settings, including hospitals, community pharmacies, research laboratories, and government agencies. Flexibility in work hours and settings Pharmacy offers a great deal of flexibility in terms of work hours and settings.

Research Laboratories 130

Research Laboratories Community Pharmacies Hospitals 130

European Pharmaceutical Review

OCTOBER 19, 2022

This is our second acquisition in gene therapy, following the 2021 acquisition of Prevail Therapeutics,” added Dr Daniel Skovronsky, Lilly’s Chief Scientific and Medical Officer and President of Lilly Research Laboratories. “With Akouos, we are optimistic that we can make a difference for people with hearing loss.”

Research Laboratories 98

Research Laboratories 98

European Pharmaceutical Review

NOVEMBER 22, 2022

Li, President of Merck Research Laboratories. “We Lysine-specific demethylase 1 (LSD1). Evidence indicates that LSD1 (KDM1A) plays an important role in the maturation of blood cells in the bone marrow,” noted Dr Dean Y.

Research Laboratories 98

Research Laboratories 98

European Pharmaceutical Review

JULY 7, 2022

At the beginning of his career in 2004, Dr Hughes was responsible for early clinical research at Bristol Myers-Squibb Company and then at Schering-Plough Research Institute. Dr Hughes earned his MD and PhD at Yale School of Medicine.

Research Laboratories 98

Research Laboratories Pharmaceutical Companies Pharmaceutical Companies Hospitals 98

Express Pharma

FEBRUARY 8, 2024

Global biopharma companies and research laboratories recognize the value of investing in their workforce—training, upskilling, and certification—to unlock the full potential of employees and optimize available resources. The organization’s mission, “From insight to outcome,” underscores its commitment to delivering tangible results.

Research Laboratories 105

Research Laboratories Vaccines 105

Pharma Mirror

SEPTEMBER 9, 2021

Multiple flow chemistry platforms have been installed into a research laboratory at the site to allow the investigation of a wide range of chemical processes, including photolysis, electrochemistry and hydrogenations, as well. Announcement of the investment follows the appointment of Professor Ian R.

Research Laboratories 52

Research Laboratories 52

European Pharmaceutical Review

NOVEMBER 4, 2022

Co-principal investigator on the study, Dr Jeffrey Petrella, Professor of Radiology and Director of the Alzheimer Imaging Research Laboratory at Duke University added: “It often takes tens of millions of dollars and many years to do a head-to-head comparison of drugs.”.

Dosage 105

Dosage Research Laboratories 105

Express Pharma

AUGUST 7, 2024

This approach developed in collaboration between an academic research laboratory and a pharmaceutical company is not just about lowering cholesterol—it’s about creating a new paradigm to design drugs that can prevent diseases by targeting proteins more cleverly.

Research Laboratories 103

Research Laboratories Pharmaceutical Companies Pharmaceutical Companies 103

LifeProNow

APRIL 30, 2023

We strongly believe in the results of the PROpel trial, which demonstrated the clinically meaningful benefit for this combination in a broad population of patients regardless of biomarker status.”

Research Laboratories 130

Research Laboratories 130

pharmaphorum

APRIL 7, 2022

Dean Li, president of Merck Research Laboratories, told the meeting that cardiovascular disease is a big opportunity as it remains an epidemic, killing 35 million people during the pandemic while COVID-19 claimed the lives of 10 million.

Research Laboratories 98

Research Laboratories 98

Pharmaceutical Business Review

JULY 15, 2024

Merck Research Laboratories president Dr Dean Li said: “The EyeBio acquisition further diversifies our late-stage pipeline with the addition of a promising candidate based on novel biology and genetics for the treatment of certain retinal diseases.

Research Laboratories 59

Research Laboratories Diabetes Labelling 59

Pharmaceutical Business Review

JULY 23, 2024

The centre will also be a hub for innovation, dedicating over half of its space to advanced research laboratories. A subsidiary of Bayer, the company aims to enhance its chemoproteomics screening capacity and further its clinical and preclinical programmes with this new facility.

Research Laboratories 59

Research Laboratories 59

Express Pharma

AUGUST 29, 2023

The triad event is well-known to bring top international and home-grown machinery manufacturers, suppliers of analytical instruments and laboratory equipment, leading pharma companies, research laboratories, consultants, industry experts and key government officials under one roof to network and unlock business opportunities.

Research Laboratories 105

Research Laboratories Packaging 105

Pharmaceutical Business Review

DECEMBER 15, 2023

Merck Research Laboratories senior vice president for global clinical development and head of late-stage oncology Dr. Marjorie Green said: “In 2021, WELIREG became the first HIF-2α inhibitor therapy approved in the U.S. Furthermore, WELIREG showed an objective response rate (ORR) of 22% against 4% for everolimus.

Research Laboratories 64

Research Laboratories 64

Pharmaceutical Technology

FEBRUARY 27, 2023

Merck and Ridgeback intend to appeal the decision and request a re-examination of the regulator’s opinion. The scientific opinion of the EMA, which has supported 16 EU national authorities’ decision to make Lagevrio available, remains in effect.

Research Laboratories 64

Research Laboratories 64

pharmaphorum

MAY 6, 2021

The company noted that Merck gained more than 100 regulatory approvals during Perlmutter’s seven-year tenure as president of Merck Research Laboratories, before retiring last year.

Research Laboratories 64

Research Laboratories 64

Pharmaceutical Business Review

SEPTEMBER 28, 2023

Merck Research Laboratories global clinical development senior vice-president Dr Joerg Koglin said: “Despite advances in the treatment of PAH over the last two decades, there is still a significant need to improve outcomes for patients.

Research Laboratories 52

Research Laboratories 52

Pharmaceutical Technology

JUNE 7, 2023

Merck Research Laboratories global clinical development vice-president Dr Elizabeth Rhee stated: “PREVYMIS has been an important addition to the care of high-risk adult CMV-seropositive patients who have received allogeneic stem cell transplants to help prevent CMV infection and disease.

Research Laboratories 52

Research Laboratories 52

pharmaphorum

APRIL 9, 2021

Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories said in a statement that the data marked the first time an anti-PD-1 therapy showed potential adjuvant treatment for patients with RCC.

Research Laboratories 59

Research Laboratories 59

Pharmaceutical Business Review

OCTOBER 16, 2023

Merck Research Laboratories global clinical development, late-stage oncology senior vice-president and head Dr Marjorie Green said: “This positive CHMP opinion builds on our efforts to treat advanced gastric and GEJ cancer in Europe, including in patients with HER2-negative disease, which accounts for vast majority of gastric cancer cases.

Chemotherapy 52

Chemotherapy Research Laboratories 52

Pharmaceutical Technology

APRIL 4, 2023

Results showed that patients treated with Padcev along with KEYTRUDA achieved a confirmed ORR of 68%. 12% experienced a complete response and 55% a partial response.

Research Laboratories 52

Research Laboratories Chemotherapy 52

Pharmaceutical Technology

AUGUST 17, 2022

The rights to the oRNA-LNP technology platform of Orna will be retained by the company, which will also progress various other fully owned programmes in oncology and genetic disease areas. In addition, Merck will make a $100m equity investment in Orna’s Series B funding round concluded recently.

Vaccines 59

Vaccines Research Laboratories Packaging 59

Pharmaceutical Technology

DECEMBER 23, 2022

Merck Research Laboratories president Dr Dean Li said: “Advances in ADC technologies are yielding a new generation of candidates designed to more precisely target and deliver potent anticancer agents to the tumour site. Merck will also make tiered royalty payments on net sales for any ADC product commercialised to Kelun-Biotech.

Research Laboratories 52

Research Laboratories 52

Pharmaceutical Technology

SEPTEMBER 28, 2022

Merck Research Laboratories global clinical development head, senior vice-president and chief medical officer Dr Eliav Barr said: “Based on compelling data from our clinical trial programme, Keytruda has become an important treatment option in Japan and now has 23 approved uses across 13 different types of cancer.

Chemotherapy 59

Chemotherapy Research Laboratories Immunity Immunization 59

pharmaphorum

MARCH 2, 2021

Keytruda’s other indications remain unaffected, and Roy Baynes, head of global clinical development at Merck Research Laboratories emphasised that Keytruda remains “foundational” for treatment of certain patients with non-small cell lung cancer.

Research Laboratories 59

Research Laboratories Chemotherapy 59

Pharmaceutical Technology

MAY 12, 2023

They have also created tissue research images at the IPU and other ICR research laboratories. Researchers at the unit are integrating digital pathology, tissue hybridisation and AI technologies to gain better understanding of major aspects of cancer pathology.

Research Laboratories 52

Research Laboratories Hospitals 52

pharmaphorum

AUGUST 5, 2020

Dr Sam Engel, associate vice president, Merck clinical research, diabetes and endocrinology, Merck Research Laboratories, said: “Data from phase 2 studies has provided compelling clinical evidence that warrants further evaluation of efinopegdutide for the treatment of NASH.”.

Diabetes 52

Diabetes Research Laboratories 52

Express Pharma

MAY 9, 2023

Multiple reports suggest that research laboratories consume up to 10x more energy and 4x more water than office spaces, which can impact not only the efficiency but also the productivity of the laboratory. To combat the same, most pharma and life sciences companies have their own sustainability goals in motion.

Packaging 98

Packaging Labelling Pharmaceutical Manufacturing Research Laboratories 98

pharmaphorum

DECEMBER 23, 2022

. “Advances in ADC technologies are yielding a new generation of candidates designed to more precisely target and deliver potent anticancer agents to the tumour site,” said Dean Li, president of Merck Research Laboratories.

Research Laboratories 52

Research Laboratories 52

pharmaphorum

SEPTEMBER 28, 2021

“Frequently diagnosed at an advanced stage, hepatocellular carcinoma has one of the highest mortality rates of solid cancers,” said Merck Research Laboratories’ clinical research head Scot Ebbinghaus. He said the company will “look forward to engaging with regulatory authorities as quickly as possible.”

Research Laboratories 52

Research Laboratories 52

pharmaphorum

OCTOBER 14, 2021

Dr Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories, said the data showing a 36% reduction in the risk of death “are compelling”.

Chemotherapy 45

Chemotherapy Research Laboratories Immunity Immunization 45